期刊文献+

人CR1-SCR1-3蛋白对急性大鼠脑缺血再灌注损伤的保护作用 被引量:2

Protective effect of CR1-SCR1-3 protein on acute cerebral ischemia and reperfusion injury in rats
原文传递
导出
摘要 目的探讨补体活化在大鼠急性脑缺血再灌注中的作用及人补体受体1型SCR1-3蛋白(CR1-SCR1-3)的保护作用。方法健康雄性SD大鼠75只,采用完全随机设计分组法分为假手术组(n=15)、CI/R组(n=30)及CI/R+CR1-SCR1-3组(n=30)。线栓法建立大鼠大脑中动脉栓塞模型,缺血1 h,再灌注24 h,对大鼠进行行为学检测,记录神经功能缺陷评分;TTC染色法测定脑梗死体积;制作脑匀浆测定大脑皮层髓过氧化物酶(MPO)活性、丙二醇(MDA)含量及超氧化物歧化酶(SOD)活性;制备切片观察大脑皮质区补体C4b沉积及病理改变。结果缺血再灌注24 h后,CR1-SCR1-3蛋白可明显改善CI/R+CR1-SCR1-3组大鼠神经功能(P<0.05);脑梗死体积亦明显减少(P<0.01);与CI/R组比较,CI/R+CR1-SCR1-3组MPO活力、MDA含量显著降低(P<0.01),而SOD活性显著增高(P<0.01);缺血脑组织皮质区原位补体C4b沉积显著减少(P<0.01),病理损伤亦明显减轻。结论补体活化参与了脑缺血再灌注损伤过程,CR1-SCR1-3蛋白对大鼠急性CI/R损伤具有保护作用。 Objective To investigate the effect of complements on acute cerebral ischemia and reper- fusion (CI/R) injury and the protective effect of complement receptor 1 (CR1)-SCR1-3 protein. Methods A total of 75 adult male Sprague-Dawley rats were randomly divided into three groups including a sham operation group (n = 15), a C]/R injury group (n =30) and a CI/R injury + CR1-SCR1-3 group (n =30). Transi ent focal cerebral ischemia was induced by intraluminal middle cerebral artery occlusion (MCAO) method. After MCAO for 1 h and reperfusion for 24 h, the effects of CR1-SCR1-3 protein on neurological deficits and cerebral infarct size were detected by neurofunctional deficit score and Trc staining, respectively. The activities of myeloperoxidase (MPO) and superoxide dismutase (SOD) and the content of malondialdehyde (MDA) in cerebral cortex were determined. The deposition of C4b in cerebral cortex and the pathological changes were also assessed. Results After CI/R injury for 24 h, CR1-SCR1-3 could significantly improve rat neurological functions (P 〈 0. 05 ) and lead to a reduction in cerebral infarct size (P 〈 0. 01 ). Pretreatment with CR1-SCR1-3 could decrease the MPO activity (P 〈 0.01 ) and the content of MDA (P 〈 0.05 ), and increase the SOD activity in cerebral cortex ( P 〈 0.01 ). Decreased C4b deposition as well as improved pathological changes were also observed in the CI,/R injury + CR1-SCR1-3 group (P 〈 0.01 ). Conclusion Complement activation plays a critical role in C/JR injury, and CR1-SCR1-3 possesses a protective effect by inhibiting the over-activation of complement system.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2013年第13期1323-1326,共4页 Journal of Third Military Medical University
基金 国家自然科学基金面上项目(30471723) 重庆市自然科学基金(CSTC2007BB5011)~~
  • 相关文献

参考文献13

  • 1Arumugam T V, Magnus T, Woodruff T M, et al. Complement media- tors in ischemia-reperfusion injury [ J ]. Clin Chim Acta, 2006, 374 (1/2) : 33 -45.
  • 2Saver J L. Improving reperfusion therapy for acute ischaemic stroke [J]. J Thromb Haemost, 2011, 9(Suppl 1 ) : 333 -343.
  • 3何莉,杨永涛,郭光金,刘高科,汪正清.sCR1-SCR15-18蛋白减轻补体介导的大鼠脑缺血/再灌注损伤[J].中国病理生理杂志,2009,25(12):2436-2440. 被引量:4
  • 4杨绍俊,张璇,汪正清.人补体受体1型SCR1-3功能域基因的克隆表达及生物活性鉴定[J].免疫学杂志,2012,28(1):64-68. 被引量:2
  • 5刘高科,何莉,杨永涛,汪正清.人补体受体1型活性片段SCR15-18在毕赤酵母中的表达、纯化及活性鉴定[J].第三军医大学学报,2009,31(6):470-473. 被引量:2
  • 6Li S, Xian J, He L, et al. The protective effect of SCR(15-18) on cerebral ischemia-reperfusion injury [ J ]. Neurol Res, 2011, 33 ( 8 ) : 866 - 874.
  • 7Costa C, Zhao L, Shen Y, et al. Role of complement component C5 in cerebral ischemia/reperfusion injury[ J]. Brain Res, 2006, 1100( 1 ) : 142 - 151.
  • 8Ducruet A F, Zacharia B E, Hickman Z L, et al. The complement cascade as a therapeutic target in intracerebral hemorrhage [ J ]. Exp Neurol, 2009, 219(2): 398-403.
  • 9Hill J H, Ward P A. The phlogistic role of C3 leu kotactic fragments in myocardial infarcts ofrats[J]. J Exp Med, 1971, 133(4) : 885 - 900.
  • 10Komotar R J, Starke R M, Arias E J, et al. The complement cas- cade: new avenues in stroke therapy [ J 1- Curt Vasc Pharmacol, 2009, 7(3) : 287 - 292.

二级参考文献47

  • 1罗雪,汪正清.人sCR1结合C3b结构域基因的克隆及在大肠杆菌中高效表达[J].第三军医大学学报,2005,27(15):1551-1554. 被引量:7
  • 2谭兵,张德纯,汪正清.重组人可溶性补体受体1型SCR15-18片段表达纯化及生物活性鉴定[J].第三军医大学学报,2007,29(10):892-895. 被引量:6
  • 3Mollnes T E, Kirschfink M. Strategies of therapeutic complement inhibition[J].Mol Immunol, 2006, 43( 1 -2) : 107 - 121.
  • 4Krych-Goldberg M, Atkinson J P. Structure-function relationships of complement receptor type 1[J]. Immunol Rev, 2001, 180:112-122.
  • 5Lazar H L, Bokesch P M, van-Lenta F, et al. Soluble human complement receptor 1 limits ischemic damage in cardiac surgery patients at high risk requiring cardiopulmonary bypass [ J ]. Circulation, 2004, 110(11 Suppl 1) : Ⅱ274 -Ⅱ279.
  • 6Daly R, Hearn M T. Expression of heterologous proteins in Pichia pastoffs: a useful experimental tool in protein engineering and production [J]. J Mol Recognit, 2005, 18(2): 119 -138.
  • 7Yin J, Li G, Ren X, et al. Select what you need : a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes [J]. J Bioteehnol, 2007, 127 ( 3 ) : 335 - 347.
  • 8Souza D G, Esser D, Bradford R, et al. APT070 (Mimcocept) , a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury [ J ]. Br J Pharmacol, 2005, 145(8) : 1027 - 1034.
  • 9Blanchard V, Gadkari R A, George A V, et al. High-level expression of biologically active glycoprotein hormones in Pichia pastoris strainsselection of strain GS115, and not X-33, for the production of biologi- cally active N-glycosylated 15N-labeled phCG [ J ]. Glycoconj J, 2008, 25 (3) : 245 - 257.
  • 10Kirkitadze M D, Kryeh M, Uhrin D, et al. Independently melting modules and highly structured intermodu/ar junctions within complement receptor type 1[J]. Biochemistry, 1999, 38(22): 7019-7031.

共引文献12

同被引文献23

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部